---
tags:
  - Pipeline Report
  - Metrics
  - Performance
  - Results
---

## Executive Summary

The **HCLS AI Factory** represents a breakthrough in precision medicine, delivering an end-to-end platform that transforms raw patient DNA sequencing data into novel drug candidates in under **5 hours**. Built on NVIDIA's accelerated computing stack and powered by advanced AI, this platform reduces what traditionally takes months of manual analysis to a streamlined, GPU-accelerated workflow. The platform comprises **3 engines** and **11 intelligence agents** spanning genomics, oncology, cardiology, neurology, rare disease, immunology, pharmacogenomics, clinical trials, imaging, single-cell analysis, and cell therapy.

### Key Achievements

| Metric | Value | Impact |
|:-------|:-----:|:-------|
| **Processing Time** | ~5 hours | 99% reduction from traditional methods |
| **Lines of Code** | 36,000+ | Production-grade implementation |
| **Annotated Variants** | 3.56M | Comprehensive genomic database |
| **Target Genes** | 201 | Clinically validated targets |
| **Druggability Rate** | 85% | High therapeutic potential |
| **Intelligence Agents** | 11 | Full clinical specialty coverage |
| **Milvus Collections** | 139 | ~47,691 vectors across all agents |
| **Services** | 21 | End-to-end platform orchestration |

---

## Platform Architecture

```
                    PRECISION MEDICINE TO DRUG DISCOVERY
    ════════════════════════════════════════════════════════════════

    ┌─────────────────┐     ┌─────────────────┐     ┌─────────────────┐
    │                 │     │                 │     │                 │
    │    ENGINE 1     │────▶│    ENGINE 2     │────▶│    ENGINE 3     │
    │                 │     │                 │     │                 │
    │   GENOMICS      │     │   RAG/CHAT      │     │   DRUG          │
    │   PIPELINE      │     │   PIPELINE      │     │   DISCOVERY     │
    │                 │     │                 │     │                 │
    │  ┌───────────┐  │     │  ┌───────────┐  │     │  ┌───────────┐  │
    │  │  FASTQ    │  │     │  │  VCF      │  │     │  │  TARGET   │  │
    │  │    ↓      │  │     │  │    ↓      │  │     │  │    ↓      │  │
    │  │  VCF     │  │     │  │  TARGET   │  │     │  │ MOLECULES │  │
    │  └───────────┘  │     │  └───────────┘  │     │  └───────────┘  │
    │                 │     │                 │     │                 │
    │  120-240 min      │     │  Interactive    │     │  Minutes        │
    └─────────────────┘     └─────────────────┘     └─────────────────┘
            │                       │                       │
            └───────────────────────┴───────────────────────┘
                                    │
                    ┌───────────────────────────────┐
                    │     NVIDIA DGX SPARK          │
                    │  128GB unified LPDDR5x | $4,699│
                    └───────────────────────────────┘
                                    │
            ┌───────────────────────┼───────────────────────┐
            │                       │                       │
    ┌───────┴───────┐   ┌──────────┴─────────┐   ┌────────┴────────┐
    │ 11 INTELLIGENCE│   │  139 MILVUS        │   │ MONITORING      │
    │    AGENTS      │   │  COLLECTIONS       │   │ Grafana +       │
    │  Clinical CDS  │   │  ~47,691 vectors   │   │ Prometheus      │
    └───────────────┘   └────────────────────┘   └─────────────────┘
```

---

## Engine 1: Genomics Pipeline

### Overview

The Genomics Pipeline transforms raw DNA sequencing data (FASTQ) into variant calls (VCF) using NVIDIA Parabricks, achieving **10-50x acceleration** over traditional CPU-based methods.

### Technical Specifications

| Component | Technology | Performance |
|:----------|:-----------|:------------|
| **Alignment** | BWA-MEM2 (GPU-accelerated) | 20-45 minutes |
| **Sorting** | Coordinate sorting with deduplication | Included |
| **Indexing** | samtools index + flagstat | 2-5 minutes |
| **Variant Calling** | Google DeepVariant (GPU) | 10-35 minutes |

### Data Flow

```
┌──────────────────────────────────────────────────────────────────────┐
│                        GENOMICS PIPELINE                              │
├──────────────────────────────────────────────────────────────────────┤
│                                                                       │
│   INPUT                    PROCESSING                    OUTPUT       │
│   ─────                    ──────────                    ──────       │
│                                                                       │
│   ┌─────────┐    ┌─────────────────────────────┐    ┌─────────┐     │
│   │ FASTQ   │    │                             │    │  BAM    │     │
│   │ R1/R2   │───▶│     NVIDIA PARABRICKS       │───▶│  File   │     │
│   │ ~200GB  │    │     fq2bam + DeepVariant    │    │ ~100GB  │     │
│   └─────────┘    │                             │    └────┬────┘     │
│                  │   ┌───────────────────────┐ │         │          │
│   ┌─────────┐    │   │ GRCh38 Reference      │ │    ┌────▼────┐     │
│   │Reference│───▶│   │ Genome (3.1GB)        │ │    │  VCF    │     │
│   │ GRCh38  │    │   └───────────────────────┘ │    │  File   │     │
│   └─────────┘    │                             │    │ ~11.7M  │     │
│                  └─────────────────────────────┘    │variants │     │
│                                                      └─────────┘     │
│                                                                       │
│   TIMING: 120-240 minutes (vs. 24-48 hours on CPU)                     │
│                                                                       │
└──────────────────────────────────────────────────────────────────────┘
```

### Performance Metrics

| Metric | Value |
|:-------|------:|
| Input Size | ~200 GB (paired-end FASTQ) |
| Output Variants | ~11.7 million |
| Processing Time | 120-240 minutes |
| GPU Utilization | 85-95% |
| Accuracy | >99% (DeepVariant) |

---

## Engine 2: RAG/Chat Pipeline

### Overview

The RAG (Retrieval-Augmented Generation) Pipeline enables natural language queries across millions of genomic variants, synthesizing AI-powered answers grounded in clinical evidence.

### Technical Specifications

| Component | Technology | Capacity |
|:----------|:-----------|:---------|
| **Vector Database** | Milvus | 3.56M embeddings |
| **Embedding Model** | BGE-small-en-v1.5 | 384 dimensions |
| **Knowledge Base** | Clinker | 201 genes, 150+ diseases |
| **LLM** | Claude (Anthropic) | claude-sonnet-4 |
| **Clinical Data** | ClinVar | 4.1M variants |
| **AI Predictions** | AlphaMissense | 71M predictions |

### Architecture

```
┌──────────────────────────────────────────────────────────────────────┐
│                         RAG/CHAT PIPELINE                             │
├──────────────────────────────────────────────────────────────────────┤
│                                                                       │
│                        ┌─────────────────┐                           │
│                        │   User Query    │                           │
│                        │ "What variants  │                           │
│                        │  affect VCP?"   │                           │
│                        └────────┬────────┘                           │
│                                 │                                     │
│                                 ▼                                     │
│   ┌─────────────────────────────────────────────────────────────┐   │
│   │                    EMBEDDING LAYER                           │   │
│   │                  BGE-small-en-v1.5                           │   │
│   │                   384 Dimensions                             │   │
│   └─────────────────────────────┬───────────────────────────────┘   │
│                                 │                                     │
│                                 ▼                                     │
│   ┌─────────────────────────────────────────────────────────────┐   │
│   │                     MILVUS VECTOR DB                         │   │
│   │  ┌──────────────┐  ┌──────────────┐  ┌──────────────┐       │   │
│   │  │   ClinVar    │  │ AlphaMissense│  │   Clinker    │       │   │
│   │  │  4.1M vars   │  │  71M scores  │  │  201 genes   │       │   │
│   │  └──────────────┘  └──────────────┘  └──────────────┘       │   │
│   └─────────────────────────────┬───────────────────────────────┘   │
│                                 │                                     │
│                                 ▼                                     │
│   ┌─────────────────────────────────────────────────────────────┐   │
│   │                      CLAUDE LLM                              │   │
│   │              Evidence Synthesis & Reasoning                  │   │
│   │                 Grounded in Citations                        │   │
│   └─────────────────────────────┬───────────────────────────────┘   │
│                                 │                                     │
│                                 ▼                                     │
│                        ┌─────────────────┐                           │
│                        │  AI Response    │                           │
│                        │  + Citations    │                           │
│                        │  + Evidence     │                           │
│                        └─────────────────┘                           │
│                                                                       │
└──────────────────────────────────────────────────────────────────────┘
```

### Knowledge Base Coverage

| Therapeutic Area | Target Genes | Key Diseases |
|:-----------------|:------------:|:-------------|
| Oncology | 45 | Breast, Lung, Colorectal Cancers |
| Neurology | 38 | ALS, FTD, Parkinson's, Alzheimer's |
| Rare Disease | 52 | Inherited Metabolic Disorders |
| Cardiovascular | 28 | Cardiomyopathy, Arrhythmia |
| Immunology | 22 | Autoimmune Disorders |
| Ophthalmology | 16 | Retinal Dystrophies |

### Sample Queries

```
Query: "What pathogenic variants are associated with VCP?"

Response: Based on clinical evidence from ClinVar and AlphaMissense:

• VCP R155H (rs121909331) - Pathogenic
  - Associated with IBMPFD (Inclusion Body Myopathy with Paget's Disease)
  - AlphaMissense Score: 0.94 (Likely Pathogenic)

• VCP R191Q (rs121909332) - Pathogenic
  - Causes familial ALS and FTD
  - 85% druggability confidence

• VCP A232E (rs121909333) - Pathogenic
  - Multi-system proteinopathy
  - Structure available: PDB 8OOI

Target Hypothesis: VCP is a validated therapeutic target for
neurodegenerative disease with known inhibitors in clinical development.
```

---

## Engine 3: Drug Discovery Pipeline

### Overview

The Drug Discovery Pipeline leverages NVIDIA BioNeMo NIM microservices to generate novel drug-like molecules from validated protein targets, complete with binding pose predictions and drug-likeness scoring.

### Technical Specifications

| Component | Technology | Function |
|:----------|:-----------|:---------|
| **Structure Retrieval** | RCSB PDB API | Cryo-EM/X-ray structures |
| **Molecule Generation** | BioNeMo MolMIM | Novel analog creation |
| **Molecular Docking** | BioNeMo DiffDock | Binding pose prediction |
| **3D Conformers** | RDKit | Energy minimization |
| **Drug Scoring** | QED + Lipinski | Drug-likeness evaluation |
| **Report Generation** | ReportLab | Professional PDF output |

### Pipeline Flow

```
┌──────────────────────────────────────────────────────────────────────┐
│                      DRUG DISCOVERY PIPELINE                          │
├──────────────────────────────────────────────────────────────────────┤
│                                                                       │
│  PHASE 1: STRUCTURE RETRIEVAL                                        │
│  ─────────────────────────────                                       │
│  ┌─────────────┐    ┌─────────────────────────────────────────┐     │
│  │   Target    │───▶│            RCSB PDB API                  │     │
│  │   (VCP)     │    │   8OOI: WT Hexamer (2.9A, Cryo-EM)      │     │
│  └─────────────┘    │   9DIL: Mutant (3.2A)                    │     │
│                     │   5FTK: +CB-5083 Inhibitor (2.3A)        │     │
│                     └─────────────────────────────────────────┘     │
│                                       │                              │
│                                       ▼                              │
│  PHASE 2: MOLECULE GENERATION                                        │
│  ────────────────────────────                                        │
│  ┌─────────────┐    ┌─────────────────────────────────────────┐     │
│  │ Seed Mol    │───▶│           BioNeMo MolMIM                 │     │
│  │  (CB-5083)  │    │      Masked Language Modeling            │     │
│  │   SMILES    │    │      Generate Novel Analogs              │     │
│  └─────────────┘    └─────────────────────────────────────────┘     │
│                                       │                              │
│                                       ▼                              │
│  PHASE 3: MOLECULAR DOCKING                                          │
│  ──────────────────────────                                          │
│  ┌─────────────────────────────────────────────────────────────┐    │
│  │                    BioNeMo DiffDock                          │    │
│  │           Diffusion-Based Docking Predictions                │    │
│  │              Binding Pose Generation                         │    │
│  └─────────────────────────────────────────────────────────────┘    │
│                                       │                              │
│                                       ▼                              │
│  PHASE 4: SCORING & RANKING                                          │
│  ──────────────────────────                                          │
│  ┌────────────────┐ ┌────────────────┐ ┌────────────────┐           │
│  │   Lipinski     │ │      QED       │ │     ADMET      │           │
│  │   Rule of 5    │ │    Score       │ │   Properties   │           │
│  │   MW <= 500     │ │   0.0-1.0      │ │   Absorption   │           │
│  │   LogP <= 5     │ │  Drug-likeness │ │   Metabolism   │           │
│  └────────────────┘ └────────────────┘ └────────────────┘           │
│                                       │                              │
│                                       ▼                              │
│  PHASE 5: REPORT GENERATION                                          │
│  ──────────────────────────                                          │
│  ┌─────────────────────────────────────────────────────────────┐    │
│  │              VCP_Drug_Candidate_Report.pdf                   │    │
│  │   - Executive Summary        - Ranked Candidates             │    │
│  │   - Structure Analysis       - Scoring Details               │    │
│  │   - Binding Site Maps        - Next Steps                    │    │
│  └─────────────────────────────────────────────────────────────┘    │
│                                                                       │
└──────────────────────────────────────────────────────────────────────┘
```

### Drug-Likeness Criteria

| Rule | Criteria | Purpose |
|:-----|:---------|:--------|
| **Lipinski Rule 1** | MW <= 500 Da | Oral bioavailability |
| **Lipinski Rule 2** | LogP <= 5 | Membrane permeability |
| **Lipinski Rule 3** | H-Bond Donors <= 5 | Absorption |
| **Lipinski Rule 4** | H-Bond Acceptors <= 10 | Solubility |
| **QED Score** | 0.0 - 1.0 | Overall drug-likeness |

---

## Intelligence Agents (11)

The platform includes 11 specialized intelligence agents, each providing RAG-powered clinical decision support within a specific medical domain. All agents share a common architecture: Streamlit UI + FastAPI backend + Milvus vector DB + Claude LLM.

### Agent Overview

| # | Agent | Collections | Key Capabilities |
|:-:|:------|:------------|:-----------------|
| 1 | **Precision Biomarker** | 11 (10 + 1 shared) | Genotype-aware biomarker interpretation, biological age estimation (PhenoAge/GrimAge), pharmacogenomic profiling |
| 2 | **Precision Oncology** | 11 (10 + 1 shared) | Molecular tumor board (MTB) decision support, CIViC/OncoKB variant annotation, therapy ranking, trial matching |
| 3 | **CAR-T Intelligence** | 11 (10 + 1 shared) | Cross-functional CAR-T cell therapy intelligence, construct comparison (4-1BB vs CD28), manufacturing and assay data |
| 4 | **Imaging Intelligence** | 10 | Medical imaging AI with 4 NVIDIA NIMs (VISTA-3D, MAISI, VILA-M3, Llama-3), DICOM ingestion via Orthanc, federated learning |
| 5 | **Precision Autoimmune** | 10 | 13 autoimmune conditions, diagnostic engine, disease timeline builder, cross-modal genomic enrichment |
| 6 | **Pharmacogenomics (PGx)** | 15 | 25 pharmacogenes, 100+ drugs, 9 CPIC dosing algorithms, 15 HLA associations, phenoconversion engine |
| 7 | **Cardiology Intelligence** | 13 (12 + 1 shared) | 6 validated risk calculators (ASCVD/HEART/CHA2DS2-VASc/HAS-BLED/MAGGIC/EuroSCORE II), GDMT optimizer (4-pillar HFrEF + HFpEF), 8 clinical workflows |
| 8 | **Neurology Intelligence** | 14 (13 + 1 shared) | 10 validated clinical scales (NIHSS, GCS, MoCA, MDS-UPDRS, EDSS, mRS, HIT-6, ALSFRS-R, ASPECTS, Hoehn & Yahr), 8 neuro sub-domains |
| 9 | **Rare Disease Diagnostic** | 14 (13 + 1 shared) | 88 rare diseases, 23 ACMG criteria, HPO phenotype matching, OMIM/Orphanet integration, gene therapy eligibility, newborn screening |
| 10 | **Clinical Trial Intelligence** | 14 (13 + 1 shared) | Protocol design, patient matching, site selection, eligibility optimization, adaptive design, safety signal detection, regulatory document intelligence |
| 11 | **Single-Cell Intelligence** | 12 (11 + 1 shared) | 57 cell types, TME profiling, spatial transcriptomics, drug response prediction, trajectory analysis, CAR-T target validation |

### Aggregate Agent Statistics

| Metric | Value |
|:-------|------:|
| Total Milvus Collections | 139 |
| Total Vectors (approx.) | ~47,691 |
| Guidelines Indexed | 51 |
| Rare Diseases Covered | 88 |
| Autoimmune Conditions | 13 |
| Cell Types Annotated | 57 |
| ACMG Criteria | 23 |
| Clinical Scales (Neurology) | 10 |
| Risk Calculators (Cardiology) | 6 |
| CPIC Dosing Algorithms (PGx) | 9 |
| HLA Associations (PGx) | 15 |

---

## Infrastructure & Monitoring

### NVIDIA DGX Spark Specifications

| Component | Specification |
|:----------|:--------------|
| **GPU** | NVIDIA GB10 (Blackwell) |
| **Unified Memory** | 128 GB LPDDR5x (shared CPU/GPU) |
| **CPU** | ARM64 Cores |
| **Storage** | 2+ TB NVMe |
| **Network** | 100 GbE |
| **Price** | $4,699 |

### Service Architecture (21 Services)

| Port | Service | Status |
|:----:|:--------|:------:|
| 8080 | Landing Page | Active |
| 5000 | Genomics Portal | Active |
| 5001 | RAG/Chat API | Active |
| 8501 | RAG Chat Interface | Active |
| 8502 | Biomarker Agent UI | Active |
| 8503 | Oncology Agent UI | Active |
| 8504 | CAR-T Agent UI | Active |
| 8505 | Imaging Agent UI | Active |
| 8506 | Autoimmune Agent UI | Active |
| 8507 | PGx Agent UI | Active |
| 8510 | Discovery Portal | Active |
| 8521 | Clinical Trial Agent UI | Active |
| 8525 | Single-Cell Agent UI | Active |
| 8526 | Rare Disease Agent UI | Active |
| 8527 | Cardiology Agent UI | Active |
| 8528 | Neurology Agent UI | Active |
| 19530 | Milvus Vector DB | Active |
| 3000 | Grafana | Active |
| 9099 | Prometheus | Active |
| 9100 | Node Exporter | Active |
| 9400 | DCGM Exporter | Active |

### Monitoring Dashboard

```
┌──────────────────────────────────────────────────────────────────────┐
│                    NVIDIA DGX SPARK GPU MONITORING                    │
├──────────────────────────────────────────────────────────────────────┤
│                                                                       │
│  ┌────────────────┐  ┌────────────────┐  ┌────────────────┐         │
│  │ GPU Utilization│  │ GPU Temperature│  │  GPU Power     │         │
│  │      85%       │  │     62 C       │  │    320W        │         │
│  │   ████████░░   │  │   ██████░░░░   │  │   ████████░░   │         │
│  └────────────────┘  └────────────────┘  └────────────────┘         │
│                                                                       │
│  ┌────────────────┐  ┌────────────────┐  ┌────────────────┐         │
│  │ CPU Utilization│  │Memory Bandwidth│  │ NVMe Throughput│         │
│  │      45%       │  │   450 GB/s     │  │   2.8 GB/s     │         │
│  │   ████░░░░░░   │  │   ███████░░░   │  │   ███████░░░   │         │
│  └────────────────┘  └────────────────┘  └────────────────┘         │
│                                                                       │
└──────────────────────────────────────────────────────────────────────┘
```

---

## Platform Statistics Summary

### Codebase Metrics

| Pipeline | Python | JavaScript | Shell | Markdown | CSS/HTML | Total |
|:---------|-------:|----------:|------:|---------:|---------:|------:|
| Genomics | 1,839 | 1,344 | 2,636 | 2,510 | 1,671 | **10,000** |
| RAG/Chat | 9,409 | 716 | 349 | 1,797 | 975 | **13,321** |
| Drug Discovery | 5,332 | - | 55 | 1,102 | 234 | **6,723** |
| Landing Page | 400 | 750 | 100 | 450 | 708 | **2,408** |
| Documentation | - | - | - | 3,540 | - | **3,540** |
| **Total** | **16,980** | **2,810** | **3,140** | **9,399** | **3,588** | **~36,000** |

### Data Assets

| Asset | Count | Source |
|:------|------:|:-------|
| Annotated Variants | 3,561,170 | VCF + Annotations |
| ClinVar Variants | 4,100,000 | NCBI ClinVar |
| AlphaMissense Predictions | 71,000,000 | DeepMind |
| Target Genes | 201 | Clinker Knowledge Base |
| Disease Associations | 150+ | Curated Database |
| Therapeutic Areas | 13 | Clinical Classification |
| Druggable Targets | 171 | Druggability Analysis |
| Milvus Collections | 139 | Across 11 agents |
| Total Vectors | ~47,691 | All agent collections |

---

## Technology Stack

### Core Technologies

| Layer | Technology | Purpose |
|:------|:-----------|:--------|
| **Compute** | NVIDIA DGX Spark ($4,699) | GPU-accelerated processing |
| **Genomics** | NVIDIA Parabricks 4.6 | Variant calling pipeline |
| **AI/ML** | NVIDIA BioNeMo NIM | Drug discovery models |
| **LLM** | Claude (Anthropic) | Natural language reasoning |
| **Vector DB** | Milvus | Similarity search |
| **Embeddings** | BGE-small-en-v1.5 | Semantic encoding |
| **Web** | Flask + Streamlit | User interfaces |
| **Monitoring** | Grafana + Prometheus | System observability |
| **Container** | Docker + NVIDIA Runtime | Service orchestration |

### AI Models

| Model | Provider | Application |
|:------|:---------|:------------|
| DeepVariant | Google | Variant calling (>99% accuracy) |
| BGE-small-en-v1.5 | BAAI | Semantic embeddings |
| Claude Sonnet 4 | Anthropic | Evidence synthesis |
| MolMIM | NVIDIA BioNeMo | Molecule generation |
| DiffDock | NVIDIA BioNeMo | Molecular docking |
| AlphaMissense | DeepMind | Pathogenicity prediction |
| VISTA-3D | NVIDIA | 3D medical image segmentation |
| MAISI | NVIDIA | Medical AI for synthetic imaging |
| VILA-M3 | NVIDIA | Vision-language medical model |

---

## Business Value

### Time Savings

| Process | Traditional | AI Factory | Improvement |
|:--------|------------:|-----------:|-----------:|
| FASTQ to VCF | 24-48 hours | 120-240 min | **50x faster** |
| Variant Interpretation | 2-4 weeks | Minutes | **1000x faster** |
| Target Identification | 1-3 months | Hours | **100x faster** |
| Lead Generation | 6-12 months | Hours | **1000x faster** |
| **Total Pipeline** | 12-18 months | ~5 hours | **99% reduction** |

### Cost Efficiency

| Factor | Impact |
|:-------|:-------|
| Hardware Investment | $4,699 single workstation (vs. $50K-$500K+ cluster) |
| Compute Time Reduction | 50-100x lower GPU hours |
| Manual Analysis Reduction | 90% fewer specialist hours |
| Iteration Speed | 10x faster hypothesis testing |
| Error Reduction | AI-validated annotations |

---

## Conclusion

The **HCLS AI Factory** delivers a production-ready platform for precision medicine to drug discovery, demonstrating the transformative potential of GPU-accelerated computing and AI in healthcare.

### Key Differentiators

- **End-to-End Integration**: Single platform from DNA to drug candidates
- **GPU Acceleration**: NVIDIA Parabricks and BioNeMo for 10-100x speedups
- **AI-Powered Insights**: Claude LLM for evidence synthesis across 11 agents
- **Clinical Grounding**: 4.1M ClinVar variants with 71M AI predictions
- **Full Specialty Coverage**: 11 intelligence agents covering oncology, cardiology, neurology, rare disease, immunology, PGx, imaging, clinical trials, single-cell, CAR-T, and biomarkers
- **Affordable Infrastructure**: Complete platform on a $4,699 NVIDIA DGX Spark
- **Production Ready**: 36,000+ lines of tested code, 21 services, 139 collections

---

!!! warning "Clinical Decision Support Disclaimer"
    The HCLS AI Factory platform and all intelligence agents described in this document are clinical decision support research tools. It is not FDA-cleared and is not intended as a standalone diagnostic device. All recommendations should be reviewed by qualified healthcare professionals. Apache 2.0 License.
